Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Stenocare

1.60 DKK

-5.33 %

Less than 1K followers

STENO

First North Denmark

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
-5.33 %
+1.59 %
+24.03 %
+264.46 %
+120.35 %
+48.42 %
-70.65 %
-79.74 %
-88.28 %

Stenocare is a Danish supplier of medical cannabis. Stenocare is the first player to have started sale of medical cannabis-based oils in Denmark. The company is now looking towards further European markets for its products. Stenocare is based in Randers, Denmark.

Read more
Market cap
69.45M DKK
Turnover
331.78K DKK
Revenue
4.76M
EBIT %
-695.17 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
26/2
2026

Annual report '25

All
Press releases
3rd party
ShowingAll content types
Press release11/21/2025, 5:41 AM

BioStock: Stenocare förvärvar Canngros

Stenocare
Press release11/21/2025, 5:41 AM

BioStock: Stenocare acquires Canngros

Stenocare
Press release11/19/2025, 6:56 PM

STENOCARE share analyst's comments on the CannGros acquisition

Stenocare

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release11/18/2025, 11:18 AM

Analyst Group: Analyst Group Comment on STENOCAREs acquisition of CannGros ApS

Stenocare
Regulatory press release11/18/2025, 8:59 AM

STENOCARE: Correction of total shares issued and total nominal share capital:

Stenocare
Regulatory press release11/17/2025, 4:56 PM

STENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal

Stenocare
Regulatory press release11/17/2025, 4:01 PM

STENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal

Stenocare
Press release10/24/2025, 12:31 PM

Analyst Group: Equity Research Report on STENOCARE - Transforms to a Profitable Growth Company

Stenocare
Press release10/22/2025, 12:54 PM

Analyst Group: Analyst Group Comment on STENOCARE’s Q3-report 2025

Stenocare
Regulatory press release10/22/2025, 6:00 AM

STENOCARE: Interim report third quarter 2025

Stenocare
Press release8/29/2025, 1:10 PM

Analyst Group: Equity Research Report on STENOCARE - Capitalizes on STENOCARE 3.0

Stenocare
Regulatory press release8/27/2025, 7:30 PM

Trading in STENOCARE shares by closely related party to board member

Stenocare
Press release8/21/2025, 10:50 AM

Analyst Group: Analyst Group Comment on STENOCARE’s Q2-report 2025

Stenocare
Regulatory press release8/21/2025, 6:00 AM

STENOCARE: Interim report second quarter 2025

Stenocare
Third party research5/19/2025, 8:05 AM

STENOCARE: Time to Capitalize on STENOCARE 3.0 - Analyst Group

STENOCARE A/S (“STENOCARE” or the “Company”) is a medical cannabis trading company with products approved and available for patients in six countries. The Company has recently launched a premium product, Astrum oil, which Analyst Group sees as an important...

Stenocare
Press release5/19/2025, 8:02 AM

Analyst Group: Equity Research Report on STENOCARE - Time to Capitalize on STENOCARE 3.0

Stenocare
Regulatory press release5/15/2025, 9:36 AM

Communiqué from the Annual General Meeting of STENOCARE

Stenocare
Third party research5/9/2025, 5:25 AM

Analyst Group Comment on STENOCARE's Q1-report

STENOCARE A/S (STENOCARE or the “Company”) published on May 8th the Company’s Q1-report for 2025.

Stenocare
Regulatory press release5/8/2025, 6:00 AM

STENOCARE: Interim report first quarter 2025

Stenocare
Press release5/2/2025, 12:35 PM

Medical Cannabis Made Permanent in Denmark: Major Milestone for Patients and STENOCARE

Stenocare
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.